o2h-ventures

PharmEnable supports early drug discovery programs by providing a rapid, cost efficient, and effective platform to identify new hit candidates. They use their unique and diverse virtual compound library in conjunction with our computational screening programs, to identify novel active chemical starting points against the most challenging biological targets

Status Active
Website http://www.pharmenable.com/
Category Pharmaceutical Enabler
Modality Digital & Small Molecule
Therapautics Area Multi Therapautics
Headquaters Cambridge, UK
Partner Precision Life
Investment Portfolio Fund Investment
Co-Investors Cambridge Enterprise, Meltwind